: Lack of association between gastric cancer and HOPQ alleles in Helicobacter pylori. Vol 48, No.3,[893][894][895][896][897][898][899][900][901][902]. Helicobacter pylori use a number of mechanisms to survive in the stomach lumen. The presence of these bacteria in the stomach can lead to gastritis and reduction in stomach acid production. Acute inflammation can directly damage to the peripheral cells that are responsible for the secretion of acid. The risk of developing gastric carcinoma is associated to heterogeneity of Helicobacter pylori virulence factors (such as cagA). The HopQ is one of the outer membrane proteins involved in bacterial adherence to gastric mucosa and has been suggested to also play a role in the virulence of H. pylori. This gene has been shown in two types. The purpose of the current study was to investigate the association between different H. pylori virulence hopQ alleles (types I and II) and patients with gastroduodenal disorders. For this purpose 58 stomach biopsies the of patients with gastric cancer and 100 saliva samples from healthy individuals were collected. Then genomic DNA was purified and PCR for was done for desired genes via specific primers. The H. pylori infections were diagnosed by PCR for GlmM gene. 
INTRODUCTION
Gastric cancer is the most universal lethal cancer with around 738,000 deaths per year (JEMAL et al., 2011) . Different frequency of gastric cancer in worldwide can be due to diversity in the genetic conditions, nutritional behaviors and living conditions (HUMANS, 1994) .
Helicobacter pylori is a gram negative and successful gastric pathogen which colonizes more than 50% of the world population (COVER and BLASER, 2009) .
The H. pylori infection is the key cause of gastric and duodenal ulcers, as well as a potential risk factor for gastric cancer and mucosa-associated tissue lymphoma (GRAHAMAND and FISCHBACH, 2010) . Available information indicates a slight association between gastroduodenal diseases and H. pylori virulence factors (ZHOU et al., 2004) .
The H. pylori is now recognized to be a significant co-factor in the aetiology of noncardia gastric cancer of both the diffuse and intestinal histological type. The latter type develops via a complex multistage and multifactorial process. The first stage involves progression from superficial gastritis to atrophic pangastritis with intestinal metaplasia and correlated hypochlorhydria. This gastric phenotype may then progress to dysplasia and gastric cancer. Many co-factors are concerned in this progression as well as the strain of H. pylori, host genetic factors, host gender and environmental factors. Intestinal colonization with helminthic infection may retard the progression by changing the immune and inflammatory response to H. pylori and colonization of the achlorhydric stomach with nitrosating bacteria may promote progression to cancer. H. pylori appears to be a necessary co-factor in the aetiology of most gastric cancers. Therefore, avoidance of the infection or its eradication in early life should reduce the occurrence of this widespread and usually fatal tumor (MCCOLL and EL-OMAR, 2002) .
If H. pylori infects the gastric epithelium cells, the interleukin-8 should be induced and production of too much amounts of toxic reactive oxygen species (ROS) may be occurred. It may induce the interferon-γ (IFN-γ), tumor necrosis factor-α (TNF-α) and some other interleukins (AUGUSTO et al., 2007) . Oxidative stress that caused by ROS is involved in human carcinogenesis (CERUTTI, 1985) . ROS generated in normal respiration of cells and during xenobiotics metabolism. It is known as a candidate agent in the growth of cancer and damage to cell membranes, mitochondria and DNA molecule (EGAN et al., 2003) . Several putative virulence factors for H. pylori have been identified including vacA, babA, and iceA. HopQ is one of the outer membrane proteins involved in bacterial adherence to gastric mucosa and has been found as a virulence factor of H. pylori. In 2005, Cao et al., reported that H. pylori hopQ genotypes are associated with an increased risk for peptic ulcer disease (CAO et al., 2005) . The H. pylori genomes include about 30 different hop genes, which encode outer membrane proteins (CAO and COVER, 2002) . LOH et al., (2008) showed that, in certain H. pylori, adherence to the gastric epithelial cells are faintly facilitated in strains expressing hopQ (Loh et al., 2008) , though they did not present further data about disease specific virulence factor of hopQ.
The high rate of H. pylori infection in Iran and the increasing number of digestive complaints lead to the current study on whether the presence of hopQ (typeI and II) can affect disease outcome.
The purpose of the current study was to investigate the association between different H. pylori virulence hopQ alleles (types I and II) and patients with gastroduodenal disorders among a sample of the Iranian population.
MATERIALS AND METHODS

Materials, chemicals and reagents
Agarose and polymerase chain reaction (PCR) materials were prepared from Fermentas. Specific primers were synthesized by Cinnaclon, Iran. All chemicals and reagents were prepared from Zagros Bioidea Co, Kermanshah, Iran.
Participants
The population consisted of gastric cancer patients and cancer-free as controls. All desired population was H. pylori infected. Gastric biopsies were taken from 58 gastric cancer patients and 100 cancer-free that were infected to H. pylori. The patients and controls were age and sex matched. The experiment materials included stomach biopsies of the patients with gastric cancer and saliva samples from healthy individuals.
DNA purification and gene amplification
The genomic DNA was purified from stomach biopsies of the patients with gastric cancer (according to MORADI et al., 2014 method) and saliva samples from buccal epithelial cells of the healthy individuals (according to AIDAR, 2007 method) .
The PCR was done for desired genes via specific primers ( The presence of H. pylori and hopQ alleles in gastric biopsy specimens and in saliva healthy samples was identified by specific PCR assays.
Statistical analysis
The  2 analysis was applied for study of different frequency in patients and healthy people. The SPSS V19 was used for Statistical analysis 
RESULTS
Genomic DNA purification
Genomic DNA from 58 gastric cancer patients and 100 cancer-free was purified successfully (Fig. 1) . The quality and quantity of purified genomic DNA was studied via spectrophotometery.
Identification of H. pylori infected samples via glmM gene PCR amplification
The H. pylori infections were identified by PCR for glmM gene. The PCR reaction for this gene amplified a fragment in 294 bp length in the H. pylori infections (Fig 2.) 
Polymerase chain reaction for hopQI gene detection:
The agarose gel electrophoresis for hopQI gene detection in the H. pylori infections via PCR has been shown in Fig. 3 . The PCR reaction for this gene in hopQI + samples amplified a fragment in 187 bp. 
The hopQI gene frequency in the H. pylori infections
The frequencies for the hopQI gene frequency in the H. pylori infections has been shown in table 4. The  2 analysis showed that there was not a significant difference between gastric cancer and healthy individuals for presence of allele in their strains (P<0.05). 
Polymerase chain reaction for hopQII gene detection
The agarose gel electrophoresis for hopQII gene detection in the H. pylori infections via PCR has been shown in Fig. 4 . The PCR reaction for this gene in hopQII + samples amplified a fragment in 160 bp. 
The hopQII gene frequency in the H. pylori infections
The frequencies for the hopQII gene frequency in the H. pylori infections has been shown in table 5. The  2 analysis showed that there was not a significant difference between gastric cancer and healthy individuals for presence of allele in their strains (P<0.05).
Table 5. The hopQII gene frequency in the H. pylori infections
The hopQI hopQII genes simultaneously frequency in the H. pylori infections
The frequencies for the hopQII hopQII genes frequency as simultaneously in the H. pylori infections has been shown in table 6. The  2 analysis showed that there was not a significant difference between gastric cancer and healthy individuals for presence of allele in their strains (P<0.05). (MOGES et al., 2006) .
Helicobacter pylori plays a key role in the pathogenesis of chronic gastritis, peptic ulceration, and noncardia gastric cancer. As it has been shown in Fig. 2 , the PCR product from gastric cancer patients biopsies (lane 1) was more efficient rather than saliva samples from healthy individuals (lane 2).
Clinical development of H. pylori infection is affected by the interaction of numerous virulence factors as well as by the host. The H. pylori infection is the key causative agent of superficial gastritis and confirms an expected role in the etiology of peptic ulcer disease (GATTI et al., 2005) .
According to the biologic concepts, achieving successful and long term colonization requires composite adhesion mechanisms for bacteria. Therefore, all potential bacterial products were under focus for investigating the possible contribution in bacterial colonization. The H. pylori HopQ is one of the main outer membrane proteins on the bacterial surface and is the major outer membrane protein family observed in H. pylori genome. Determining a link between H. pylori hopQ and convinced digestive diseases may provide a start point for answering questions regarding H. pylori adherence to gastric cells. This study was designed to determine the frequency of H. pylori hopQ genotypes isolated from biopsy specimens. Our findings demonstrate a moderate prevalence of H. pylori hopQ types I and II genotype among Iranian patients with gastric cancer and healthy individuals that are infected to H. pylori. TALEBI BEZMIN ABADI and MOHABBATI MOBAREZ (2014) reported a high prevalence of H. pylori hopQ type II genotype among Iranian patients with gastric cancer that is not according to our finding. It has been suggested that specific genotyping-based analysis of H. pylori isolates can be helpful for predicting post infection disorders (LU et al., 2005) .
Recent findings have shown that the hopQ type I allele is strongly associated with an increased risk of peptic ulcer diseases (PUD) in western countries and that H. pylori hopQ II is frequently detected among investigated population (OHNO et al., 2009) .
Furthermore, outer membrane proteins of H. pylori have shown a strong potential for increasing the severity of related gastroduodenal disorders. OHNO et al., (2009) In an investigation by OHNO et al., (2009 ) the prevalence of hopQ I among gastritis and gastric cancer patients reported 58% and 68%, respectively. However, our results indicate that the frequency of hopQ I was almost similar in both H. pylori infected healthy individuals and gastritis patients (46.4% and 53.8%, resp.). TALEBI BEZMIN ABADI and MOHABBATI MOBAREZ (2014) reported that hopQ I is the less prevalent genotype among the H. pylori isolates recovered from the Iranian population. In contrast to a study from United States (CAO and COVER, 2002) which reported a significant association between the carriage of H. pylori hopQ type I among the peptic ulcer patients, OHNO et al., (2009) did not identify a relationship between both hopQ alleles and clinical outcomes of infection (P > 0.05). It has been reported that hopQ type II strains have low frequency (less than 1%) among the Far East countries. Data from western countries indicate that the prevalence of hopQ type II strains (36%) is more common than countries from eastern Asia (1%). Our data about hopQ type II frequency is related to H. pylori infected persons not in a random population.
In conclusion, this study showed that hopQ I and II genotype is frequently present in H. pylori strains isolated from gastric cancer patients and healthy individuals in Iran. Then hopQ can not be a virulence and risk factor in our population
